Nightingale Health’s mission is to build sustainable healthcare and reduce health inequalities. Nightingale Health has developed the world’s most advanced health check for the health industry. Their solution provides risk detection for multiple chronic diseases from a single blood sample. Nightingale's Health Check can be scaled to entire populations at a low cost, and can replace many current risk assessments. Detecting disease risks on a population level allows effective targeting and tracking of health interventions, and better prevention of the onset of chronic diseases. With every sample, Nightingale Health helps to create a healthier world.

Nightingale Health operates globally with a parent company in Finland and seven subsidiaries in countries such as Japan, the United States, Singapore, and the United Kingdom. They have customers in more than 25 countries in healthcare and medical research. Their technology is used in many world-leading health initiatives, such as the UK Biobank, and over 600 peer-reviewed publications validate the technology.

Their headquarters and laboratory are located in Helsinki, Finland, with additional laboratories and offices in Kuopio, Finland; Tallinn, Estonia; Berlin, Germany; Tokyo, Japan; Singapore; Stockholm, Sweden; London, United Kingdom; and Williamsville, United States.